
New 2D-LC–MS Approaches for the Analysis of In-Process Samples and for the Characterisation of mAbs in a Regulated Environment
Biologics, and in particular monoclonal antibodies (mAbs), are an important class of therapeutics, and their market share keeps growing. The production of antibodies is a complex and lengthy process.